While significant therapeutic advancements, including liver transplantation, siRNA-based TTR silencing, and tetramer stabilizers targeting specific genetic mutations, have improved outcomes in ATTRv,15,16,17 therapeutic options for age-related ATTRwt amyloidosis remain limited; tetramer stabilizers have only recently become available.43 Here, TTR is linked to amyloidosis.